The COVID-19 vaccine-maker Pfizer-BioNTech said Monday that its three-dose vaccine was about 80% effective in preventing symptomatic infection in children under 5, meaning shots for the youngest population could come within weeks.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.